Study of AZD9829 in CD123+ Hematological Malignancies

Clinical trial NCT06179511 · COMPLETED

Trial details

NCT number: NCT06179511
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematological Malignancies

Start date: 2024-01-31
Primary completion: 2025-10-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.